PRCT PROCEPT BioRobotics Corp
Company Analysis
Latest News
Procept BioRobotics third quarter 2026 revenue of $98.3 million misses estimates despite 22% procedure growth
Procept BioRobotics reported third quarter 2026 revenue of $98.3 million, missing analyst expectations of $100.52 million. The net loss widened to $0.46 per...
Procept Biorobotics Corp Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Procept Biorobotics Corp is expected to report Q3 2026 revenue of $100.52 million and a loss per share of $0.39, with its current stock price of $20.16 trading...
Investment Firm Chicago Capital Substantially Increases Stake in Procept Biorobotics
Investment firm Chicago Capital, LLC has significantly increased its investment in Procept Biorobotics, according to an SEC filing dated October 22, 2025. The...
Procept Biorobotics Named to Time Magazine's 'America's Growth Leaders of 2026'
Procept Biorobotics Corp. was recognized as one of America's top-performing publicly listed companies in Time Magazine's inaugural "America's Growth Leaders of...
Procept Biorobotics Stock Hits New 52-Week Low
Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) reached a new 52-week low on Tuesday, October 14, 2025. The company's stock traded as low as $32.46...